Dystrophin replacement strategies require widespread distribution of protein expression in skeletal and cardiac tissue in sufficient concentrations to compensate for the lack of functional dystrophin in patients with DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.